Marizyme, Inc. (MRZM)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Oct 2, 2025
Marizyme Revenue
Marizyme had revenue of $183.42K in the twelve months ending September 30, 2024, down -68.96% year-over-year. In the year 2023, Marizyme had annual revenue of $645.81K with 176.60% growth.
Revenue (ttm)
183.42K
Revenue Growth
-68.96%
P/S Ratio
0.00
Revenue / Employee
14.11K
Employees
13
Market Cap
132.00
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seelos Therapeutics | 2.01M |
| Q BioMed | 209.29K |
| RVL Pharmaceuticals | 36.92M |
| NanoLogix | 1.27K |
| Navidea Biopharmaceuticals | 610.00 |
| Infinity Pharmaceuticals | 2.57M |
| American Oriental Bioengineering | 121.58M |
| Cardax | 500.71K |